Connecticut State Department of Children and Families

Psychotropic Medication Advisory Committee (PMAC)

The FDA Warns Against the Use of Many Genetic Tests with Unapproved Claims to Predict Patient Response to Specific Medications: FDA Safety Communication

2019 Minutes

March
February
January

December
November
October
May
April
March
February

Handouts:

Appendix II Psychotropic Medication Monitoring Protocols (April 2019)
CYP Metabolism of Psychotropic Medications 
Drug Review and Decision History by Date (July 2015)
Drug Review and Decision History by Drug (July 2015)
Drug Lists:
     Brand Name/Generic Name Drug List (June 2016)
     Generic Name/Brand Name Drug List (June 2016)
Guidelines for Psychotropic Medication Use in Children and Adolescents